Literature DB >> 25763753

Bisphosphonate therapy in metastatic carcinoma patients with chronic renal failure: are bisphosphonates an enemy or crony?

Fatos Dilan Koseoglu1, Cagatay Arslan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25763753     DOI： 10.1007/s00520-015-2672-2

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  13 in total

1.  Elimination and clearance of pamidronate by haemodialysis.

Authors:  Mirena Buttazzoni; Guillermo J Rosa Diez; Victor Jager; Maria S Crucelegui; Salomon L Algranati; Luisa Plantalech
Journal:  Nephrology (Carlton)       Date:  2006-06       Impact factor: 2.506

2.  The issue of renal safety of zoledronic acid from a nephrologist's point of view.

Authors:  József Balla
Journal:  Oncologist       Date:  2005-05

Review 3.  Differences in nephrotoxicity of intravenous bisphosphonates for the treatment of malignancy-related bone disease.

Authors:  Raoul Bergner; Ingo J Diel; Dirk Henrich; Martin Hoffmann; Michael Uppenkamp
Journal:  Onkologie       Date:  2006-10-25

Review 4.  The kidney and bisphosphonates.

Authors:  Paul D Miller
Journal:  Bone       Date:  2011-01-11       Impact factor: 4.398

5.  Bisphosphonate treatment recommendations for oncologists.

Authors:  Roger von Moos
Journal:  Oncologist       Date:  2005

6.  Removal of clodronate by haemodialysis in end-stage renal disease patients.

Authors:  A E Beigel; E Rienhoff; C J Olbricht
Journal:  Nephrol Dial Transplant       Date:  1995-12       Impact factor: 5.992

7.  Pharmacokinetics of clodronate in renal failure.

Authors:  H Saha; P Castren-Kortekangas; S Ojanen; A Juhakoski; J Tuominen; O Tokola; A Pasternack
Journal:  J Bone Miner Res       Date:  1994-12       Impact factor: 6.741

8.  Elimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study.

Authors:  Raoul Bergner; Katja Dill; Dietmar Boerner; Michael Uppenkamp
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

Review 9.  Is there a role for bisphosphonates in chronic kidney disease?

Authors:  Paul D Miller
Journal:  Semin Dial       Date:  2007 May-Jun       Impact factor: 3.455

10.  American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

Authors:  Robert A Kyle; Gary C Yee; Mark R Somerfield; Patrick J Flynn; Susan Halabi; Sundar Jagannath; Robert Z Orlowski; David G Roodman; Patricia Twilde; Kenneth Anderson
Journal:  J Clin Oncol       Date:  2007-05-21       Impact factor: 44.544
View more
  1 in total

1.  Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.

Authors:  Sara Mahmoud; Hassan Mitwally; Hani Soliman El Zeer; Ihab El Madhoun; Mohamad Khatib
Journal:  Am J Case Rep       Date:  2018-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.